2-[[2-[(3R)-3-aminopiperidin-1-yl]-6-(difluoromethyl)-4-oxothieno[3,2-d]pyrimidin-3-yl]methyl]benzonitrile;tert-butyl N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-6-(difluoromethyl)-4-oxothieno[3,2-d]pyrimidin-2-yl]piperidin-3-yl]carbamate;tert-butyl N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-6-formyl-4-oxothieno[3,2-d]pyrimidin-2-yl]piperidin-3-yl]carbamate
C70H73F4N15O8S3 — CID 161330062
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[2-[(3R)-3-aminopiperidin-1-yl]-6-(difluoromethyl)-4-oxothieno[3,2-d]pyrimidin-3-yl]methyl]benzonitrile;tert-butyl N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-6-(difluoromethyl)-4-oxothieno[3,2-d]pyrimidin-2-yl]piperidin-3-yl]carbamate;tert-butyl N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-6-formyl-4-oxothieno[3,2-d]pyrimidin-2-yl]piperidin-3-yl]carbamate
2-[[2-[(3R)-3-aminopiperidin-1-yl]-6-(difluoromethyl)-4-oxothieno[3,2-d]pyrimidin-3-yl]methyl]benzonitrile;tert-butyl N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-6-(difluoromethyl)-4-oxothieno[3,2-d]pyrimidin-2-yl]piperidin-3-yl]carbamate;tert-butyl N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-6-formyl-4-oxothieno[3,2-d]pyrimidin-2-yl]piperidin-3-yl]carbamate (PubChem CID 161330062) has the molecular formula C70H73F4N15O8S3 and a molecular weight of 1424.64 g/mol. Its IUPAC name is 2-[[2-[(3R)-3-aminopiperidin-1-yl]-6-(difluoromethyl)-4-oxothieno[3,2-d]pyrimidin-3-yl]methyl]benzonitrile;tert-butyl N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-6-(difluoromethyl)-4-oxothieno[3,2-d]pyrimidin-2-yl]piperidin-3-yl]carbamate;tert-butyl N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-6-formyl-4-oxothieno[3,2-d]pyrimidin-2-yl]piperidin-3-yl]carbamate.
Molecular Properties
| Compound Name | 2-[[2-[(3R)-3-aminopiperidin-1-yl]-6-(difluoromethyl)-4-oxothieno[3,2-d]pyrimidin-3-yl]methyl]benzonitrile;tert-butyl N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-6-(difluoromethyl)-4-oxothieno[3,2-d]pyrimidin-2-yl]piperidin-3-yl]carbamate;tert-butyl N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-6-formyl-4-oxothieno[3,2-d]pyrimidin-2-yl]piperidin-3-yl]carbamate |
|---|---|
| PubChem CID | 161330062 |
| Molecular Formula | C70H73F4N15O8S3 |
| Molecular Weight | 1424.64 g/mol |
| Exact Mass | 1423.49 |
| IUPAC Name | 2-[[2-[(3R)-3-aminopiperidin-1-yl]-6-(difluoromethyl)-4-oxothieno[3,2-d]pyrimidin-3-yl]methyl]benzonitrile;tert-butyl N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-6-(difluoromethyl)-4-oxothieno[3,2-d]pyrimidin-2-yl]piperidin-3-yl]carbamate;tert-butyl N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-6-formyl-4-oxothieno[3,2-d]pyrimidin-2-yl]piperidin-3-yl]carbamate |
| SMILES | CC(C)(C)OC(=O)N[C@@H]1CCCN(c2nc3cc(C(F)F)sc3c(=O)n2Cc2ccccc2C#N)C1.CC(C)(C)OC(=O)N[C@@H]1CCCN(c2nc3cc(C=O)sc3c(=O)n2Cc2ccccc2C#N)C1.N#Cc1ccccc1Cn1c(N2CCC[C@@H](N)C2)nc2cc(C(F)F)sc2c1=O |
| InChI | InChI=1S/C25H27F2N5O3S.C25H27N5O4S.C20H19F2N5OS/c1-25(2,3)35-24(34)29-17-9-6-10-31(14-17)23-30-18-11-19(21(26)27)36-20(18)22(33)32(23)13-16-8-5-4-7-15(16)12-28;1-25(2,3)34-24(33)27-18-9-6-10-29(14-18)23-28-20-11-19(15-31)35-21(20)22(32)30(23)13-17-8-5-4-7-16(17)12-26;21-18(22)16-8-15-17(29-16)19(28)27(10-13-5-2-1-4-12(13)9-23)20(25-15)26-7-3-6-14(24)11-26/h4-5,7-8,11,17,21H,6,9-10,13-14H2,1-3H3,(H,29,34);4-5,7-8,11,15,18H,6,9-10,13-14H2,1-3H3,(H,27,33);1-2,4-5,8,14,18H,3,6-7,10-11,24H2/t17-;18-;14-/m111/s1 |
| InChIKey | VLHJMLJMCKAUHE-SEPFWTDKSA-N |
| XLogP | 11.74 |
| TPSA | 305.51 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 100 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1424.64 |
| LogP ≤ 5 | 11.74 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 24 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161330062 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.